on Carl Zeiss Meditec AG (ETR:AFX)
Bronwyn Brophy O'Connor Appointed CEO of Carl Zeiss Meditec Group
On December 1, 2026, Bronwyn Brophy O'Connor will step into the role of CEO at Carl Zeiss Meditec AG. The announcement, made on October 26, 2026, marks a significant leadership change as she takes over from interim CEO Andreas Pecher. Brophy O'Connor, with robust credentials from Vitrolife Group in Sweden, will also join the Executive Board of Carl Zeiss AG, managing the Medical Technology segment.
This transition is poised to bolster Carl Zeiss Meditec's innovation and customer-focused growth. Her extensive background, spanning multiple international companies like Johnson & Johnson and Medtronic, equips her well for the strategic development of the group's medical technology efforts. Chairman Peter Kameritsch and Dr. Michael Bolle anticipate her strong leadership will further the company's transformation and success.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Carl Zeiss Meditec AG news